1. Multifunctional neuron-specific enolase: its role in lung diseases
   Cai-Ming Xu et al, 2019, Bioscience Reports CrossRef
2. CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
   Sofi Isaksson et al, 2017, PLOS ONE CrossRef
3. Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
   Shaohua Cui et al, 2017, Tumor Biology CrossRef
4. Biomarkers and Target Therapy for Lung Cancer
   Olga V. Shneider et al, 2021, Physical and rehabilitation medicine, medical rehabilitation CrossRef
5. Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib
   MINEHIKO INOMATA et al, 2016, Molecular and Clinical Oncology CrossRef
6. Clinical value of Pro‑GRP and T lymphocyte subpopulation for the assessment of immune functions of lung cancer patients after DC‑CIK biological therapy
   Lijie Lijie et al, 2017, Experimental and Therapeutic Medicine CrossRef
7. Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations
   Juanjuan Dong et al, 2021, Cancer Management and Research CrossRef
8. Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma
   Qiongjie Zhi et al, 2016, Oncotarget CrossRef
9. Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapies
   Michel van den Heuvel et al, 2024, Tumor Biology CrossRef
10. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update
    Inga Trulson et al, 2024, Tumor Biology CrossRef